Ambulatory Status Over Time after Revascularization in Patients with Chronic Limb-Threatening Ischemia.


Journal

Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298

Informations de publication

Date de publication:
01 Jun 2022
Historique:
pubmed: 28 5 2021
medline: 7 6 2022
entrez: 27 5 2021
Statut: ppublish

Résumé

Maintaining functional status through revascularization is a major goal in patients with chronic limb-threatening ischemia (CLTI). Nevertheless, there is a lack of clarity on the impact of revascularization on mobility over time. This study examined ambulatory status over time after revascularization and predictors of ambulation loss in CLTI patients. We used a clinical database established by the Surgical reconstruction versus Peripheral INtervention in pAtients with critical limb isCHemia study, a prospective, multicentre, observational study including patients with CLTI. The primary endpoint was mobility over time. Of the 381 patients, the ambulatory proportion at baseline was 71%. The proportion gradually decreased, finally reaching 40% at 36 months. In non-ambulatory patients at revasacularisation, approximately 20-40% of patients achieved ambulation. Multivariate analysis confirmed that age, impaired mobility before CLTI onset and at revascularization, renal failure on dialysis, and WIfI clinical stage 4 were positively associated with ambulation loss at either specific or all time points, whereas male sex and surgical reconstruction were inversely associated with the outcomes at specific time points. Mobility in the overall population gradually decreased, whereas the number of deceased patients increased. Advanced age, impaired mobility before CLTI onset and at revascularization, renal failure on dialysis, and WIfI stage 4 were associated with ambulation loss at almost all points after revascularization.

Identifiants

pubmed: 34039832
doi: 10.5551/jat.62892
pmc: PMC9174083
doi:

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

866-880

Références

J Vasc Surg. 2014 Feb;59(2):350-8
pubmed: 24139567
Trials. 2016 Jan 06;17:11
pubmed: 26739146
J Vasc Surg. 2015 Dec;62(6):1642-51.e3
pubmed: 26391460
J Vasc Surg. 1997 Feb;25(2):287-95; discussion 295-7
pubmed: 9052563
Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33
pubmed: 31182334
J Vasc Surg. 2007 Jan;45 Suppl S:S5-67
pubmed: 17223489
Circ Cardiovasc Interv. 2019 Dec;12(12):e008015
pubmed: 31771341
Arch Gerontol Geriatr. 2017 Jan - Feb;68:135-142
pubmed: 27810661
Trials. 2017 May 19;18(1):224
pubmed: 28526046
J Atheroscler Thromb. 2021 Jan 1;28(1):44-51
pubmed: 32188794
Eur J Surg. 1998 Jan;164(1):35-43
pubmed: 9537707
J Vasc Surg. 2019 Jun;69(6S):137S-151S.e3
pubmed: 30497863
J Vasc Surg. 2006 Jun;43(6):1183-90
pubmed: 16765235
Vascular. 2014 Dec;22(6):411-20
pubmed: 24476584
Ann Vasc Surg. 2011 Oct;25(7):873-7
pubmed: 21831588
Circulation. 2017 Mar 21;135(12):e726-e779
pubmed: 27840333
Semin Vasc Surg. 2014 Mar;27(1):82-4
pubmed: 25812762
J Vasc Surg. 2009 Jun;49(6):1431-9.e1
pubmed: 19497502
J Vasc Surg. 2010 Feb;51(2):360-71.e1
pubmed: 20141960
Eur J Vasc Endovasc Surg. 2012 Apr;43(4):420-5
pubmed: 22305646
J Vasc Surg. 2014 Nov;60(5):1282-1290.e1
pubmed: 25242270
Eur J Vasc Endovasc Surg. 2015 Apr;49(4):412-9
pubmed: 25747173
Circ Cardiovasc Interv. 2017 Dec;10(12):
pubmed: 29246911
Eur J Vasc Endovasc Surg. 2014 Dec;48(6):695-702
pubmed: 25281532
JACC Cardiovasc Interv. 2017 Jun 12;10(11):1147-1157
pubmed: 28595883
Eur J Vasc Endovasc Surg. 2019 Oct;58(4):548-555
pubmed: 31409542
Ann Vasc Surg. 2006 Nov;20(6):753-60
pubmed: 16791454
J Vasc Surg. 2018 Nov;68(5):1473-1481
pubmed: 29803684
J Vasc Surg. 2006 Oct;44(4):747-55; discussion 755-6
pubmed: 16926083

Auteurs

Akio Kodama (A)

Division of Vascular Surgery, Department of Surgery, Nagoya University School of Medicine.

Mitsuyoshi Takahara (M)

Department of Diabetes Care Medicine, and Department of Metabolic Medicine, Osaka University Graduate School of Medicine.

Osamu Iida (O)

Cardiovascular Center, Kansai Rosai Hospital.

Yoshimitsu Soga (Y)

Department of Cardiology, Kokura Memorial Hospital.

Hiroto Terashi (H)

Department of Plastic Surgery, Kobe University Graduate School of Medicine.

Daizo Kawasaki (D)

Cardiovascular Center, Morinomiya Hospital.

Yuichi Izumi (Y)

Nayoro City General Hospital.

Shinsuke Mii (S)

Department of Vascular Surgery, Saiseikai Yahata General Hospital.

Kimihiro Komori (K)

Division of Vascular Surgery, Department of Surgery, Nagoya University School of Medicine.

Nobuyoshi Azuma (N)

Department of Vascular Surgery, Asahikawa Medical University.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH